Next Article in Journal
Synthesis of 2-Izopropyl-5-methylphenylcarboxymethylen Tartrate
Previous Article in Journal
Computational Approaches for Structure-Based Functional Annotation of an Uncharacterized Conserved Protein of Acinetobacter baumannii
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Biosynthesis and Characterization of Copper Oxide Nanoparticles †

National Institute for Research and Development in Microtechnologies—IMT Bucharest, 126A Erou Iancu Nicolae, 077190 Bucharest, Romania
*
Authors to whom correspondence should be addressed.
Presented at the 2nd International Electronic Conference on Processes: Process Engineering—Current State and Future Trends (ECP 2023), 17–31 May 2023; Available online: https://ecp2023.sciforum.net/.
Eng. Proc. 2023, 37(1), 54; https://doi.org/10.3390/ECP2023-14629
Published: 17 May 2023

Abstract

:
In this paper, we report the use of the natural extract of Echinacea leaves [Echinacea purples] for the biosynthesis of copper oxide nanoparticles, with copper nitrate [Cu(NO3)2 3H2O] used as a metal precursor salt. The synthesized CuO was investigated using Fourier transform infrared spectrometry (FTIR), Raman spectroscopy, X-ray diffraction, scanning electron microscopy (FESEM), and energy dispersive X-ray analysis (EDX). The FTIR spectra confirm not only the presence of the Cu-O bond by the appearance of the characteristic peak at 402 cm−1, but also the presence of the functional groups characteristic of the biomolecules present in the plant extracts used. The Raman spectra indicate peaks at wavelengths of 272 and 610 cm−1, which are characteristic bands for CuO. The XRD diffractogram indicates the formation of a monoclinic crystalline structure by the appearance of distinctive peaks corresponding to (110), (002), and (111) planes, with an average crystallite size of 15 nm. The SEM images reveal the formation of spherical particles with dimensions below 40 nm. The EDX spectrum confirms the presence of the peaks attributed to (C) and (O) atoms without other impurities. Due to the small size, morphology, and precise elemental composition of CuO NPs, this approach allows the synthesis of biomaterials with applicability in the development of antibacterial agents and biosensors.

1. Introduction

Ecological approaches regarding the synthesis of metal oxide nanoparticles have attracted special attention due to their ability to prevent environmental contamination and improve quality of life and human well-being. Among metal oxide nanoparticles, CuO nanoparticles (NPs) have attracted particular interest due to their distinctive physical and chemical properties, as well as their antibacterial, antioxidant, and antifungal characteristics, based on which they have expanded their applicability in many biomedical, industrial, agricultural, electronic, and environmental applications, etc. [1,2]
Until now, many researchers have reported different approaches for synthesis, namely: sol-gel, coprecipitation, hydrothermal, solid-state reaction, thermal decomposition of precursors, microemulsion, sonochemical, and photochemical reduction. Pure and well-defined CuO NPs can be obtained using the presented methods, but have the disavantages of raw materials, various surfactants and other process conditions, by releasing wastes harmful to the environment and human health. In this context, the biogenic method was considered an alternative to the known physical and chemical methods. This process is emerging as an economic and sustainable approach and has gained significant attention due to its use of less harmful substances and biological systems (e.g., plants, fungi, yeast, algae, bacteria, etc.) with low adverse effects and high biocompatibility. Among these, the suitable parts (e.g., leaves, flowers, fruit, root, etc.) are the most common components in the synthesis of nanoparticles due to their non-toxicity, easy handling, and low purchase price. The applicability of natural extracts is given by the phytochemical compounds, such as phenols, flavonoids, carboxylic acids, terpenoids, tannins, etc., which act as both reducing and capping agents for the formation of CuO NPs and can affect physico-chemical characteristics, stability, and toxicity. The morphology of the oxide nanoparticles is influenced by the reducing potential of the bioactive compounds, which is determined by the type and amount of extract, the concentration and ratio of the main raw materials, the pH of the solution, the process temperature, etc. [3,4,5,6].
From a survey of the literature, we found that there exist studies on the biosynthesis of CuO that use different types of plants and substances derived from them, such as Aloe vera, Psidium guajava, Ruellia tuberosa, Tribulus terrestris, Pterospermum acerifolium, Galeopsidis herba, Gloriosa superb, Chamomile, Ocimum sanctum, etc., to synthesize nanostructures of different shapes (nanoparticles, nanorods, nanoflowers, nanospheres, or clusters) with dimensions in the nanometric range. CuO NPs obtained using biosynthesis methods have an efficiency against ethylene blue (MB) dye, excellent antibacterial, antioxidant, and antifungal properties, and can be considered a candidate for photocatalytic as well as antimicrobial activity [7,8].
Echinacea purpurea is a medicinal herb belonging to the Asteraceae family, which contains chicoric acid as the dominant component (among the phenylpropanoids), along with phenolic compounds such as flavonoids, tannins, alkaloids, starch, furochromones, and glycosides. It can be used as a reducing and stabilizing agent in the synthesis of different types of nanoparticles due to its antibacterial, antiproliferative, inhibitory, and antioxidant properties. This plant gained its reputation due to its phytochemical compounds and special properties, which are used in different practical applications for oral consumption, skin treatment, intestinal pain, etc. However, there are few studies in the literature on the use of Echinacea extract in the biosynthesis of nanoparticles. However, it has been found that by using Echinacea purpurea extract as a reducing and capping agent, nanoparticles of ZnO, TiO2, Ag, and Au, with sizes below 100 nm, can be synthesized with antibacterial susceptibility against both Gram positive (S. aureus) and Gram negative (E. coli) bacteria and have enhanced antioxidant effects and antimicrobial properties (against Escherichia coli and Candida albicans) [9,10,11].
In this paper, we report an eco-friendly and simple approach for the synthesis of CuO NPs using a natural extract of Echinacea leaves [Echinacea purples] as a reducing and capping agent. The synthesized particles were investigated using FTIR and Raman spectroscopy, X-ray diffraction, FESEM microscopy, and EDX analysis. The results of this study offer a good understanding of the process parameters and the types of extracts (in our case, Echinacea) that can be used to synthesize CuO NPs, as well as the extension of their applicability in various fields depending on the obtained properties (e.g., shape, size, composition, structure etc.).

2. Experimental Detail

2.1. Synthesis of CuO Nanoparticles

For the biosynthesis of CuO nanoparticles, we used the natural extract of Echinacea leaves [Echinacea purples], copper nitrate [Cu(NO3)2 3H2O], sodium hydroxide [NaOH], and deionized water [H2O]. All chemicals were purchased from Sigma-Aldrich (Munchen, Germany) without any further purification, and the required solutions were prepared in deionized water. The dried Echinacea leaves were washed to remove dust particles, after which a quantity of 10 g was added to 100 mL of deionized water (DIW) and heated at 100 °C for 2 h. The mixture was then cooled to room temperature, and the extract was filtered using Whatman filter paper No: 1 (Merck, Darmstadt, Germany). To synthesize the CuO NPs, Echinacea extract was added dropwise over the aqueous solution of Cu(NO3)2 3H2O [0.1M] under continuous stirring using a magnetic stirrer at a temperature of ~80 °C for 2 h, after which the solution became dark green. The ratio between the main components was Cu(NO3)2: Echinacea extract = 2:1. The NaOH solution [0.1 M] was added drop by drop to the obtained solution until the pH = 12. This reaction was then left for 3 h, under continuous stirring at a temperature of ~80 °C. After the reaction had finished and a brown precipitate formed, the solution was left to rest for 24 h. Then, the obtained precipitate was centrifuged at 9000 rpm for 20 min and washed three times with DIW. The powder was dried at 100 °C for 4 h, followed by thermal treatment at 450 °C for 3 h, with an oven heating speed of 5 °C/min, in order to obtain a brownish-black powder.

2.2. Characterization

The FTIR spectra for the CuO sample were recorded using a Tensor 27 FTIR spectrometer (Bruker Optics, Germany). The spectral range was 4000–370 cm−1, with a resolution of 4 cm−1, at room temperature, and averaging 64 scans using an ATR Platinum holder. The Raman spectra were collected at room temperature using a Witec Raman spectrometer (Alpha-SNOM 300 S, WiTec. GmbH, Germany) with 532 nm as an excitation. The diffraction pattern for the CuO sample was collected using a Rigaku Smartlab diffractometer using monochromatic Cu-Kα radiation, operating at 7a current of 5 mA and a voltage of 40 kV. The intensity data were recorded in the range between 20° and 95°. To assess the morphology and particle size of the CuO sample, a field emission scanning electron microscope (FEI Company, Hillsboro, OR, USA) was used. The CuO NPs were dispersed in an organic solvent, deposited on a silicon substrate, and allowed to dry overnight. The elemental analysis of synthesized particles was carried out using an energy dispersive X-ray analyzer (EDX) (Smart Insight AMETEK, Mahwah, USA) attached to SEM equipment.

3. Results and Discussions

3.1. FTIR Analysis

Figure 1 shows the ATR-FTIR spectra for both the Echinacea extract (a) and the CuO NPs obtained from the extract (b) to establish the possible phytochemical compounds responsible for the bioreduction, capping, and stabilization of the CuO. The characteristic spectrum of the extract (Figure 1a) indicates the presence of metabolites (e.g., flavonoids, alkaloids, terpenes, etc.), which are responsible for the process of reduction and stabilization of the nanoparticles. Table 1 shows the possible assignments of the spectral bands both for the extract and for the oxide nanoparticles obtained. The FTIR spectrum of the CuO sample (Figure 1b) confirms the occurrence of the characteristic peak at 402 cm−1, which can be attributed to the vibrations of Cu-O, but also the presence of the functional groups characteristic of the biomolecules present in the extract, which indicate the presence of C-O stretching alcohols, carboxylic acids, esters, and ethers. In Figure 1b, a peak of high intensity centered at around 402 cm−1 can be observed, which can be associated with the vibration mode of the Cu-O bonds, as well as peaks of reduced intensity that are shifted towards higher wave numbers as compared to the extract due to the anchoring of the molecules from the extract on the surface of the oxide nanoparticles.

3.2. RAMAN Analysis

The Raman spectrum of the CuO nanoparticles is presented in Figure 2, having been obtained in the range 100–1000 cm−1 at room temperature. The recorded spectrum shows the presence of three scattering bands, with peaks located at 272, 333, and 610 cm−1. The peak centered at 272 cm−1 is assigned to the Ag mode, and the other two peaks at 333 and 610 cm−1 are assigned to the Bg modes. No active modes related to other phases, or any impurities, were detected, which indicates the formation of monoclinic phase CuO.

3.3. XRD Analysis

The XRD pattern of the CuO synthesized using the Echinacea extract is shown in Figure 3. The XRD pattern indicates the formation of a monoclinic crystalline structure by the appearance of the well-defined diffraction peaks observed at 2θ = 32.47°, 35.52°, and 38.63°. These distinctive peaks can be assigned to the (110), (002), and (111) crystallographic planes of the monoclinic structure of CuO with lattice parameters: a = 4.6936 Å, b = 3.42834 Å, and c = 5.1377 Å, according to the International Center for Diffraction Data (ICDD), card no. 080-1916, and other data that exist in the literature [5,14].
No other peaks characteristic of secondary phases such as Cu2O or other impurities were detected, which confirmed the high purity of the sample. The average crystallite size of CuO NPs was calculated using the Debye equation, D = kλ/βcosθ, where D is the average crystalline size (Å), k is the shape factor: 0.93, λ is the wavelength of X-ray radiation, and β is the full width at half maximum (FWHM) of the peaks at the diffracting angle θ, and was found to be 15 nm.

3.4. SEM Analysis

Figure 4 shows the morphology of the CuO sample obtained using Echinacea extract. From the examination of the SEM image, the formation of spherical particles was found, and most of them were found in the agglomerated form. The synthesized nanoparticles had sizes varying between 15 and 40 nm.

3.5. EDX Analysis

The elemental composition of the CuO sample is presented in Figure 5. In the EDX spectrum of the analyzed sample, only the peaks attributed to Cu and O elements are present, confirming the purity of the synthesized material. The weight and atomic compositions of the main elements (Cu and O) are presented in the inset table of the EDX spectrum.

4. Conclusions

CuO nanoparticles were obtained using a convenient and eco-friendly method in which an aqueous extract of Echinacea was used as a biological reducing and stabilization agent. The FTIR and Raman spectra of the oxide sample confirmed the existence of Cu-O bonds as well as the existence of molecules from the extract on the surface of the nanostructured oxide. The XRD patterns suggest the nature of crystallinity in the formation of the CuO NPs, accompanied by a crystallite size in the range of 8–25 nm. A spherical morphology with the agglomerated form of nanoparticles and a size range from 15 to 45 nm was determined from SEM analysis. The results of this study provide information about the performance of these nanoparticles, which allows for the expansion of their applicability in the food industry, agriculture sector, and biomedical sciences.

Author Contributions

A.M. conceived, planned, and conducted the experiments for the synthesis of the CuO nanoparticles; FTIR characterization, V.T.; XRD characterization, C.R.; SEM and EDX characterization, G.C.; RAMAN characterization, C.P.; writing—original draft preparation, A.M.; writing—review and editing, A.M., V.T., C.R., G.C., and C.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Core Program within the National Research Development and Innovation Plan 2022–2027 and conducted with the support of MCID, project no. 2307 (µNanoEl).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

This work was supported by the Core Program within the National Research Development and Innovation Plan 2022–2027 and conducted with the support of MCID, project no. 2307 (µNanoEl).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Khan, S.A.; Shahid, S.; Sajid, M.R.; Noreen, F.; Kanwal, S. Biogenic synthesis of CuO nanoparticles and their biomedical applications: A current review. Int. J. Adv. Res. 2017, 5, 925–946. [Google Scholar] [CrossRef] [PubMed]
  2. Khatoon, U.T.; Mohan Mantravadi, K.; Nageswara Rao, G.V.S. Strategies to synthesis copper oxide nanoparticles and their bio applications—A review. Mater. Sci. Technol. 2018, 34, 2214–2222. [Google Scholar] [CrossRef]
  3. Keabadile, O.P.; Aremu, A.O.; Elugoke, S.E.; Fayemi, O.E. Green and traditional synthesis copper oxide nanoparticles—Comparative study. Nanomaterials 2020, 10, 2502. [Google Scholar] [CrossRef] [PubMed]
  4. Matei, A.; Tucureanu, V.; Popescu, M.; Romanitan, C.; Bita, B.; Cernica, I. Synthesis and characterization of various surfactants for stabilized CuO powder. Mater. Res. Proc. 2018, 8, 52–60. [Google Scholar]
  5. Akintelu, S.A.; Folorunso, A.S.; Folorunso, F.A.; Oyebamiji, A.K. Green synthesis of copper oxide nanoparticles for biomedical application and environmental remediation. Heliyon 2020, 6, e04508. [Google Scholar] [CrossRef] [PubMed]
  6. Negrescu, A.M.; Killian, M.S.; Raghu, S.N.V.; Schmuki, P.; Mazare, A.; Cimpean, A. Metal Oxide Nanoparticles: Review of Synthesis, Characterization and Biological Effects. J. Funct. Biomater. 2022, 13, 274. [Google Scholar] [CrossRef] [PubMed]
  7. Siddiqi, K.S.; Husen, A. Current status of plant metabolite-based fabrication of copper/copper oxide nanoparticles and their applications: A review. Biomater. Res. 2020, 24, 11. [Google Scholar] [CrossRef] [PubMed]
  8. Siddiqui, H.; Qureshi, M.S.; Haque, F.Z. Biosynthesis of flower-shaped CuO nanostructures and their photocatalytic and antibacterial activities. Nano-Micro Lett. 2020, 12, 29. [Google Scholar] [CrossRef] [PubMed]
  9. Attar, A.; Altikatoglu, M. Biomimetic synthesis, characterization and antibacterial efficacy of ZnO and Au nanoparticles using echinacea flower extract precursor. Mater. Res. Express 2018, 5, 055403. [Google Scholar] [CrossRef]
  10. Dobrucka, R. Synthesis of titanium dioxide nanoparticles using echinacea purpurea Herba. Iran. J. Pharm. Res. 2017, 16, 756–762. [Google Scholar] [PubMed]
  11. Fierascu, I.C.; Fierascu, I.; Baroi, A.M.; Ungureanu, C.; Ortan, A.; Avramescu, S.M.; Somoghi, R.; Fierascu, R.C.; Dinu-Parvu, C.E. Phytosynthesis of biological active silver nanoparticles using Echinacea purpurea L. Extracts. Materials 2022, 15, 7327. [Google Scholar] [CrossRef] [PubMed]
  12. Al-Hakkani, M.F.; Gouda, G.A.; Hassan, S.; Nagiub, A.M. Echinacea purpurea Mediated Hematite Nanoparticles (α-HNPs) Biofabrication, Characterization, Physicochemical Properties, and its In-vitro Biocompatibility Evaluation. Surf. Interfaces 2021, 24, 101113. [Google Scholar] [CrossRef]
  13. Pawlaczyk, I.; Czerchawski, L.; Pilecki, W.; Lamer-Zarawska, E.; Gancarz, R. Polyphenolic-polysaccharide compounds from selected medicinal plants of Asteraceae and Rosaceae families: Chemical characterization and blood anticoagulant activity. Carbohydr. Polym. 2009, 3, 568–575. [Google Scholar] [CrossRef]
  14. Joya, M.R.; Barba-Ortega, J.; Raba, A.M. Vibrational Raman modes and particle size analysis of cupric oxide with calcination temperature. Indian J. Pure Appl. Phys. 2019, 57, 268–271. [Google Scholar]
Figure 1. FTIR spectra of (a) Echinacea extract; (b) CuO NPs synthesized from Echinacea extract.
Figure 1. FTIR spectra of (a) Echinacea extract; (b) CuO NPs synthesized from Echinacea extract.
Engproc 37 00054 g001
Figure 2. RAMAN spectrum of CuO NPs synthesized from Echinacea extract.
Figure 2. RAMAN spectrum of CuO NPs synthesized from Echinacea extract.
Engproc 37 00054 g002
Figure 3. XRD diffraction patterns of CuO NPs synthesized from Echinacea extract.
Figure 3. XRD diffraction patterns of CuO NPs synthesized from Echinacea extract.
Engproc 37 00054 g003
Figure 4. SEM images of CuO NPs synthesized from Echinacea extract.
Figure 4. SEM images of CuO NPs synthesized from Echinacea extract.
Engproc 37 00054 g004
Figure 5. EDX spectrum of CuO NPs synthesized from Echinacea extract.
Figure 5. EDX spectrum of CuO NPs synthesized from Echinacea extract.
Engproc 37 00054 g005
Table 1. Possible assignments of the FTIR spectral bands of Echinacea extract and the CuO NPs [12,13].
Table 1. Possible assignments of the FTIR spectral bands of Echinacea extract and the CuO NPs [12,13].
Possible AssignmentsFromWavenumber [cm−1]
Echinacea CuO
O-HStretching vibration from phenols hydroxyl groups 3300-
-C-HAliphatic stretching vibration2926-
2855-
C=OStretching vibration band of esterified carbonyl groups overlap with carboxylic group1730-
C=O+ C=C, νC=O conjugated to the aromatic ring1598
C=OStretching vibrations of carboxylic group14141425
S=OStretching vibration from sulfate ester1330-
C-O Stretching vibrations 1246-
S=OStretching vibration from sulfate ester1151-
C–OStretching vibration band10221037
Cu-OCuO-402
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Matei, A.; Craciun, G.; Romanitan, C.; Pachiu, C.; Tucureanu, V. Biosynthesis and Characterization of Copper Oxide Nanoparticles. Eng. Proc. 2023, 37, 54. https://doi.org/10.3390/ECP2023-14629

AMA Style

Matei A, Craciun G, Romanitan C, Pachiu C, Tucureanu V. Biosynthesis and Characterization of Copper Oxide Nanoparticles. Engineering Proceedings. 2023; 37(1):54. https://doi.org/10.3390/ECP2023-14629

Chicago/Turabian Style

Matei, Alina, Gabriel Craciun, Cosmin Romanitan, Cristina Pachiu, and Vasilica Tucureanu. 2023. "Biosynthesis and Characterization of Copper Oxide Nanoparticles" Engineering Proceedings 37, no. 1: 54. https://doi.org/10.3390/ECP2023-14629

APA Style

Matei, A., Craciun, G., Romanitan, C., Pachiu, C., & Tucureanu, V. (2023). Biosynthesis and Characterization of Copper Oxide Nanoparticles. Engineering Proceedings, 37(1), 54. https://doi.org/10.3390/ECP2023-14629

Article Metrics

Back to TopTop